Axa’s NewtekOne NEWT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-22,350
Closed -$365K 1193
2022
Q3
$365K Sell
22,350
-600
-3% -$12.2K ﹤0.01% 1012
2022
Q2
$434K Sell
22,950
-7,450
-25% -$179K ﹤0.01% 990
2022
Q1
$812K Sell
30,400
-2,200
-7% -$59.3K ﹤0.01% 978
2021
Q4
$901K Buy
32,600
+19,700
+153% +$578K ﹤0.01% 963
2021
Q3
$358K Buy
+12,900
New +$392K ﹤0.01% 1113
2021
Q2
Sell
-36,800
Closed -$983K 1283
2021
Q1
$983K Hold
36,800
﹤0.01% 981
2020
Q4
$725K Hold
36,800
﹤0.01% 1022
2020
Q3
$683K Hold
36,800
﹤0.01% 992
2020
Q2
$670K Buy
36,800
+22,920
+165% +$363K ﹤0.01% 1017
2020
Q1
$183K Buy
13,880
+80
+0.6% +$1.52K ﹤0.01% 1102
2019
Q4
$313K Hold
13,800
﹤0.01% 1072
2019
Q3
$312K Hold
13,800
﹤0.01% 1180
2019
Q2
$317K Buy
+13,800
New +$301K ﹤0.01% 1152
2018
Q3
Sell
-24,200
Closed -$482K 1365
2018
Q2
$482K Sell
24,200
-400
-2% -$7.58K ﹤0.01% 1139
2018
Q1
$445K Buy
24,600
+13,900
+130% +$246K ﹤0.01% 1186
2017
Q4
$198K Sell
10,700
-56,500
-84% -$1M ﹤0.01% 1311
2017
Q3
$1.2M Buy
67,200
+2,600
+4% +$44.4K 0.01% 925
2017
Q2
$1.05M Hold
64,600
﹤0.01% 923
2017
Q1
$1.1M Buy
+64,600
New +$1.05M 0.01% 914
2016
Q1
Sell
-21,000
Closed -$301K 1377
2015
Q4
$301K Hold
21,000
﹤0.01% 1110
2015
Q3
$345K Buy
+21,000
New +$371K ﹤0.01% 1117

Other funds holding NEWT

Axa's NEWT Position: Q4 2022 in Review

Axa sold out of NewtekOne (NEWT) in Q4 2022, closing a stake of 22,350 shares — an estimated $365K sold.

Axa first reported a position in NEWT in Q3 2015 and held it in 21 quarters. The position peaked at $1.2M in Q3 2017. 69 funds tracked by Wall St. Rank hold NEWT as of Q4 2022.

  • Axa reported no remaining NewtekOne position as of Q4 2022 after selling out during the quarter.
  • Axa sold 22,350 NewtekOne shares in Q4 2022, an estimated $365K.
  • Axa first reported a position in NewtekOne in Q3 2015 and held it in 21 quarters.
  • Axa's NewtekOne position peaked at $1.2M in Q3 2017.
  • 69 funds tracked by Wall St. Rank held NewtekOne as of Q4 2022.

Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.